bit.bio raises €45.0M Series C round

The funding will be used to accelerate product development, expand global operations, move into the toxicology market, and generate high-fidelity datasets for training advanced AI models for drug discovery.

Source: https://bit.bio/news-and-events/bit.bio-secures-50-million-series-c-to-scale-human-cell-programming-technology/